Abiopharma

Tanguler Tolga 🟡 adjusted position in 2.3K shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) at $377.82 Transaction Date: Jan 11, 2026 | Filing ID: 000012

New Form 424B3 - cbdMD, Inc. Filed: 2026-01-14 AccNo: 0001437749-26-001272 Size: 448 KB

HENRY DAVID A 🟢 acquired 8.7K shares of MYOMO, INC. (MYO) Transaction Date: Jan 12, 2026 | Filing ID: 012949

Cutler Scott 🔴 sold 12.5K shares of HEALTHEQUITY, INC. (HQY) at $89.83 ($1.1M) Transaction Date: Jan 12, 2026 | Filing ID: 000004

New Form 3 - EDAP TMS SA Filed: 2026-01-14 AccNo: 0001829126-26-000301 Size: 18 KB

New Form 424B3 - Vivos Therapeutics, Inc. Filed: 2026-01-14 AccNo: 0001493152-26-002251 Size: 324 KB

New Form S-3 - ClearPoint Neuro, Inc. Filed: 2026-01-14 AccNo: 0001683168-26-000309 Size: 559 KB

New Form 3 - EDAP TMS SA Filed: 2026-01-14 AccNo: 0001829126-26-000302 Size: 15 KB

(99% Neutral) BiomX Inc. (PHGE) Announces New Board Appointment

Coherent Executive and Technical Experts to Showcase Thought Leadership at SPIE BiOS and Photonics West 2026

BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027

(99% Neutral) Safety Shot Inc (SHOT) Announces New Board Appointment

ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech (ALVO) for Potential Securities Fraud Following Massive FDA-Induced Stock Crash

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.